INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
PB

Pfeiffenberger Brent

Director, President and CEOCIK 0002001162

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells2 / 1
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$27K
13.8K sh
Sep 11, 2026Sep 15, 2026
traded Sep 11, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Century Therapeutics, Inc.Director, President and CEO · Nov 19, 2025
11
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F
$977
463 sh
Sep 4, 2026
Sep 9, 2026
traded Sep 4, 2026
+5d
SEC FORM 4

Evidence

8
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$60K
31.2K sh
Aug 14, 2026Aug 18, 2026
traded Aug 14, 2026
+4dSEC FORM 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$31K
13.8K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$986
463 sh
Jun 5, 2026Jun 9, 2026
traded Jun 5, 2026
+4dSEC FORM 4

Evidence

8
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$73K
31.2K sh
May 15, 2026May 19, 2026
traded May 15, 2026
+4dSEC FORM 4

Evidence

8
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$151K
55.4K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$1,185
463 sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

9
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Grant or award
A—
475.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Grant or award
A—
945.0K sh
Feb 2, 2026Feb 4, 2026
traded Feb 2, 2026
+2dSEC FORM 4

Evidence

30
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Open-market purchase
BUY$30K
52.0K sh
Dec 12, 2025Dec 16, 2025
traded Dec 12, 2025
+4dSEC FORM 4

Evidence

5
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$244
463 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

36
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Open-market purchase
BUY$17K
35.0K sh
Nov 19, 2025Nov 20, 2025
traded Nov 19, 2025
+1dSEC FORM 4

Evidence

31
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$15K
32.5K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence